[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(11/11, WED) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)

 머크, 한미 'GLP/GCG' MASH 2b상 "긍정적" 란셋 게재  
[https://www.biospectator.com/news/view/30364](https://www.biospectator.com/news/view/30364)

 사노피, "3상 시작" 알테오젠 기술 '듀피젠트SC' 전략은
[https://www.biospectator.com/news/view/30331](https://www.biospectator.com/news/view/30331)

 앱클론, 'CD19 CAR-T' 유럽특허 등록.."주요 8개국 완료" 
[https://www.biospectator.com/news/view/30371](https://www.biospectator.com/news/view/30371)

 아젠엑스, ‘거대고리 펩타이드’ UNP 11.5억弗 인수
[https://www.biospectator.com/news/view/30356](https://www.biospectator.com/news/view/30356)

 베링거, ‘GLP-1/GCG’ 3상 "심혈관 안전성+대사 개선"
[https://www.biospectator.com/news/view/30358](https://www.biospectator.com/news/view/30358)

 HLB파나진, ‘HPV 분자진단’ 멕시코 의료기기 "허가"
[https://www.biospectator.com/news/view/30370](https://www.biospectator.com/news/view/30370)

 베라더믹스, ‘경구 미녹시딜’ 2/3상 장기 “탈모 더 개선” 
[https://www.biospectator.com/news/view/30355](https://www.biospectator.com/news/view/30355)

 셀트리온, MSCI ESG 평가 최고등급 'AAA' 첫 획득
[https://www.biospectator.com/news/view/30373](https://www.biospectator.com/news/view/30373)

 SK바이오사이언스, KCGS 평가 "5년 연속 통합 A등급"
[https://www.biospectator.com/news/view/30374](https://www.biospectator.com/news/view/30374)

 바이엘, ‘경구 FXIa 저해제' 뇌졸중 재발예방 "美 승인"
[https://www.biospectator.com/news/view/30367](https://www.biospectator.com/news/view/30367)

[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(11/11, WED) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)